Used as a key intermediate in pharmaceutical synthesis, particularly in Suzuki-Miyaura cross-coupling reactions to construct complex organic molecules. Its boronic ester group enables efficient carbon-carbon bond formation, making it valuable in the development of active pharmaceutical ingredients (APIs). The cyano and methyl functional groups enhance reactivity and selectivity, allowing fine-tuning of molecular structure in drug discovery. Commonly applied in the synthesis of kinase inhibitors and other bioactive compounds. Stable and compatible with a range of reaction conditions, it supports high-yield transformations in medicinal chemistry.